학술논문
Safety and immunogenicity of a mutagenized, live attenuated Rift Valley fever vaccine, MP-12, in a Phase 1 dose escalation and route comparison study in humans
Document Type
Article
Author
Source
In Vaccine 20 January 2016 34(4):424-429
Subject
Language
ISSN
0264-410X